Tag: NSCLC
Single-Agent Pembrolizumab Active Against STK11– and KEAP1– Mutated NSCLC According to...
By Kara Nyberg, PhD
Posted: June 24, 2020
Genomic alterations in STK11 and KEAP1 represent two of the most common and potent contributors to a cold...
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
Improved Turnaround Times for Biopsy Results Matters More Than Type of Biopsy
By Dr. Edgardo S. Santos Castillero, MD, FACP
Posted: December 11, 2019
Regarding “Liquid Biopsy for Assessing...
Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?
By Si-Yang Liu, MD, and Yi-Long Wu, MD
Posted: November 12, 2019
In the twentieth century, adjuvant chemotherapy became the standard of care for resected NSCLC...